CD56 ANTIGEN;
MEMBRANE METALLOENDOPEPTIDASE;
PROTEIN BCL 6;
ADULT;
ARTICLE;
CASE REPORT;
DIFFERENTIAL DIAGNOSIS;
HUMAN;
LARGE CELL LYMPHOMA;
MALE;
METABOLISM;
MULTIMODALITY CANCER THERAPY;
NK T CELL LYMPHOMA;
PATHOLOGY;
The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma
Park S, Lee J, Ko YH, et al. The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma. Blood, 2007, 110(3):972-978.
Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8;21) (q22;q22)
Baer MR, Stewart CC, Lawrence D, et al. Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t (8;21) (q22;q22). Blood, 1997, 90(4):1643-1648.
Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome
Chang H, Brandwein J, Yi QL, et al. Extramedullary infiltrates of AML are associated with CD56 expression, 11q23 abnormalities and inferior clinical outcome. Leuk Res, 2004, 28(10):1007-1011.